Asceneuron receives regulatory approval for phase 1 healthy volunteer study of oral tau inhibitor
admin 10th April 2017 Uncategorised 0B3C newswire
More: Asceneuron receives regulatory approval for phase 1 healthy volunteer study of oral tau inhibitor
Source: MDlinx